Moxifloxacin versus amoxycillin clavulanate in the treatment of acute maxillary sinusitis: A primary care experience

International Journal of Clinical Practice

Volumn 55, Issue 5, 2001, Pages 309-315

  Rakkar, S ^a,d   Roberts, K ^b   Towe, B F ^c   Flores, S M ^d   Warner, J ^d  

^a Medical Center of Plano   (United States)

^b Thomson Family and Occupational Medicine ^*

^c 1 10 Medical Associates   (United States)

^d BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT; MOXIFLOXACIN; PHENYLEPHRINE; ANTIINFECTIVE AGENT; HETEROCYCLIC COMPOUND; QUINOLINE DERIVATIVE; QUINOLONE DERIVATIVE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; EVALUATION; EXPERIENCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXILLA SINUSITIS; MULTICENTER STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; POPULATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SELF CONCEPT; STATISTICAL ANALYSIS; TREATMENT OUTCOME; ADOLESCENT; DRUG COMBINATION; MIDDLE AGED;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MAXILLARY SINUSITIS; MIDDLE AGED; PROSPECTIVE STUDIES; QUINOLINES; TREATMENT OUTCOME;

EID: 0034743452     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Agency for Health Care Policy and Research. Diagnosis and treatment of acute bacterial rhinosinusitis. Rockville MD: AHCPR, 1999.
2. Gwaltney JM. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23: 1209-1225.
3. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head NeckSurg 1997; 117: 51-57.
4. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2000; 123(suppl): 4-32.
5. Brooks I, Gooch WM, Jenkins SG et al. Medical management of acute bacterial sinusitis: recommendations of a clinical advisory committee on pediatrie and adult sinusitis. Ann Otol Rhinol Laryngol 2000; 182(suppl): 2-20.
6. Thornsberry C, Ogilvie P, Kahn J et al. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophi/us influenzae, and Moraxella caiarrhalis in the United States in 1996-1997 respiratory season. Diagn Micwbiol Infect Dis 1997; 29: 249-257.
7. Thornsherry C, Jones ME, Hickey ML et al. Resistance surveillance of Streptococcus pneumoniae, Haemophilus injluenzae and Moraxella catarrhalis isolates in the United States. 1997-1998. J Antimicmh Chenwiher 1999; 44: 749-759.
8. Doern GV, Pfaller MA. Kugler K et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 1998; 27: 764-770.
9. Doern GV, Jones RN, Pfaller MA, Kugler K, for the SENTRY Participants Group. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 1999; 43: 385-389.
10. Camacho AE, Cobo R, Otte J et al. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis Am J Med 1992: 93: 271-276.
11. Henry DC, Sydnor A Jr. Settipane GA e 1 til. Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis. Clin Ther 1999; 21: 1158-1170.
12. Klapan I. Culig J. Oreskovic K et al. Azithromycin vs amoxicillin/clavulanate in the treatment of acute sinusitis. Am J Otolarynxol 1999; 20: 7-11.
13. Klein GL, Whalen E, Echols RM. Heyd A. Ciprotloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. J Otolaryngol 1998:27: 10-16.
14. Johnson PA. RodrigueJ. HP, Wazen JJ et al. Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. J Otolaryngol 1999; 28: 3-12.
15. Clifford K. Huck W, Shan M et al. Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. Ann Otol Rhino/ Laryngol 1999; 108: 360 367.
16. Adelglass J, De Abate CA, McElvaine P et aJ. Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. Otolaryngol Head Neck Surf; 1999; 120: 320-327.
17. Adelglass J, Jones TM, Ruoff G el al. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. Pharmacotherapy 1998; 18: 1255-1263.
18. Burke T, Villanueva C, Mariano H et al. Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitis. Clin Ther 1999; 21: 1664-1677.
19. Baz M, Jannetti W, Villanueva C et al. The efficacy and tolerability of moxifloxacin compared to trovafloxacin in the treatment of acute sinusitis. Todays Therapeutic Trends 1999; 17: 303-319.
20. Siegert R, Bagger-Sjoback D, Gehanno P, Nikolaidis P. Short course treatment of acute sinusitis with moxifloxacin versus cefuroxime axetil. Proceedings of the 9th European Congress of Clinical Microbiology and Infectious Diseases, Berlin. Germany, May 21-24, 1999. Abstract P0721.
21. Brueggemann AB, Kugler KC, Doern GV. In vitro activity of BAY 128039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella calarrhalis. Antimicmh Agents Chemother 1997; 41: 15941597.
22. Gehanno P, Stass H, Arvis P. Penetration of moxifloxacin (MFX) into sinus tissues following multiple oral dosing Presented at the European Congress of Clinical Microbiology and Infectious Diseases, 1998.
23. Jacobs MR. Bajaksouzian S, Zilles A el al. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study. Antimicrob Agents Chemother 1999; 43: 1901-1908.
24. Brook I.Gooch WM, Jenkins SO. Pichichero ME. Medical management of acute bacterial sinusitis: recommendations of a clinical advisory committee on pediatrric and adult sinusitis. Ann Otol Rhinol Laryngol 2000: 109: 2-20.